Cassava Sciences update: SAVA stock price collapses after much-criticized Alzheimer’s drug flops
New Alzheimer’s blood tests may be headed to your doctor’s office. Here’s what to know
FDA approves a second Alzheimer’s drug shown to delay cognitive decline
Researchers develop blood test that can reliably detect Alzheimer’s disease
Researchers train AI to spot Alzheimer’s disease ahead of diagnosis